Vitamin Shoppe, Inc.

Delisted

CIK 0001360530AcceleratedRetail-Food StoresDelawareFY ends Dec 29

Period

FY 2018

Revenue

$1.11B

Net Income

$-3.75M

Total Assets

$388.08M

Equity

$188.34M

Shares Out

24.10M

Op. Cash Flow

$90.15M

Business

Vitamin Shoppe, Inc. is a former operating company in Food Stores, incorporated in Delaware. Securities are no longer actively traded on a major U.S. exchange.

Auto-generated from company profile

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31
Net sales	1,114	1,146	1,239	—	—
Cost of goods sold	759	784	820	848	809
Gross profit	355	363	420	419	404
Selling, general and administrative expenses	345	332	329	329	302
Goodwill, tradename and store fixed-assets impairment charges	3	275	797,000	1	—
Income (loss) from operations	7	−245	90	89	103
Gain on extinguishment of debt	17	0	0	—	—
Interest expense, net	7	10	10	1	495,000
Income (loss) before provision (benefit) for income taxes	17	−254	80	88	102
Provision (benefit) for income taxes	4	−19	29	35	41
Net income (loss) from continuing operations	14	−235	51	—	—
Net loss from discontinued operations, net of tax	−17	−17	−26	—	—
Net income (loss)	−4	−252	25	53	61
Basic (in shares)	23	23	24	29	30
Diluted (in shares)	23	23	24	29	31
Basic (in dollars per share)	0.58	−10.17	2.14	—	—
Diluted (in dollars per share)	0.58	−10.17	2.13	—	—
Basic (in dollars per share)	−0.74	−0.73	−1.1	—	—
Diluted (in dollars per share)	−0.74	−0.73	−1.09	—	—
Basic (in dollars per share)	−0.16	−10.9	1.05	1.84	2.03
Diluted (in dollars per share)	−0.16	−10.9	1.04	1.82	2

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31
Cash and cash equivalents	3	2	3	15	12
Inventories	189	218	242	227	187
Prepaid expenses and other current assets	28	39	34	25	30
Current assets held for sale	0	23	—	—	—
Total current assets	220	282	286	275	247
Property and equipment, net	123	142	139	140	141
Intangibles, net	11	11	79	87	89
Deferred taxes	32	37	17	—	—
Other long-term assets	2	3	2	3	3
Noncurrent assets held for sale	0	17	—	—	—
Total assets	388	491	734	749	722
Revolving credit facility	0	12	11	8	8
Accounts payable	40	47	66	41	37
Deferred sales	5	6	—	—	—
Accrued expenses and other current liabilities	61	57	52	48	53
Current liabilities held for sale	0	5	—	—	—
Total current liabilities	106	127	134	117	121
Convertible notes, net	56	126	121	115	—
Deferred rent	37	41	37	40	39
Other long-term liabilities	1	2	2	615,000	702,000
Commitments and contingencies	—	—	—	—	—
Preferred stock, $0.01 par value; 250,000,000 shares authorized and no shares issued and outstanding at December 29, 2018 and December 30, 2017	0	0	0	0	—
Common stock, $0.01 par value; 400,000,000 shares authorized, 24,234,651 shares issued and 23,974,031 shares outstanding at December 29, 2018, and 24,220,509 shares issued and 24,021,948 shares outstanding at December 30, 2017	242,000	242,000	236,000	260,000	301,000
Additional paid-in capital	86	89	81	140	267
Treasury stock, at cost; 260,620 shares at December 29, 2018 and 198,561 shares at December 30, 2017	−7	−7	−6	−5	−3
Retained earnings	110	113	365	340	287
Total stockholders equity	188	195	440	475	552
Total liabilities and stockholders equity	388	491	734	749	722

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31
Depreciation and amortization of fixed and intangible assets	42	39	39	38	34
Impairment charges on goodwill	0	211	33	0	0
Impairment charges on intangible assets	8	59	7	0	0
Impairment charges on fixed assets	11	7	797,000	1	—
Loss on sale of FDC Vitamins, LLC	203,000	0	0	—	—
Amortization of deferred financing fees	604,000	898,000	957,000	237,000	164,000
Amortization of debt discount on convertible notes	3	5	5	223,000	0
Deferred income taxes	6	−20	−14	−1	−4
Deferred rent	−4	−2	−3	−2	−503,000
Equity compensation expense	3	6	6	5	7
Issuance of shares for services rendered	0	0	333,000	167,000	0
Tax benefits on exercises of equity awards	792,000	1	739,000	509,000	−5
Accounts receivable	−1	1	70,000	3	1
Inventories	33	11	−13	−38	−2
Prepaid expenses and other current assets	12	−6	−9	4	4
Other long-term assets	−16,000	−598,000	116,000	−139,000	2
Accounts payable	−7	−13	27	−4	−10
Deferred sales	−255,000	501,000	−15	—	—
Accrued expenses and other current liabilities	5	7	3	394,000	8
Other long-term liabilities	−497,000	2	747,000	3	1
Net cash provided by operating activities	90	56	93	—	—
Capital expenditures	−28	−55	−40	−39	−43
Net proceeds on sale of FDC Vitamins, LLC	15	0	0	—	—
Trademarks and other intangible assets	−372,000	−428,000	−291,000	−514,000	−689,000
Net cash used in investing activities	−14	−55	−40	—	—
Borrowings under revolving credit facility	163	118	82	47	15
Repayments of borrowings under revolving credit facility	−175	−117	−79	−47	−7
Purchases of convertible notes	−64	0	0	—	—
Bank overdraft	601,000	−3	−1	7	0
Payments of capital lease obligations	−477,000	−451,000	−207,000	−80,000	−152,000
Proceeds from exercises of common stock options	0	2	90,000	1	9
Issuance of shares under employee stock purchase plan	290,000	469,000	823,000	892,000	923,000
Purchases of treasury stock	−304,000	−580,000	−1	−3	−2
Purchases of shares under Share Repurchase Programs	0	0	−66	−146	−58
Tax benefits on exercises of equity awards	0	0	−739,000	−509,000	5
Deferred financing fees and other	17,000	−346,000	−14,000	—	—
Net cash used in financing activities	−76	−2	−65	—	—
Effect of exchange rate changes on cash and cash equivalents	1,000	35,000	19,000	129,000	44,000
Net increase (decrease) in cash and cash equivalents	721,000	−886,000	−12	3	−62
Interest paid	3	4	4	440,000	249,000
Income taxes (refunded) paid	−15	7	34	—	—
Liability for purchases of property and equipment	2	4	5	7	8
Assets acquired under capital leases	0	891,000	2	0	0
Assets acquired under tenant incentives	0	3	0	0	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro